Manager × security

Redmile Group, LLC NRIX holdings history

Who else holds this security? →

NURIX THERAPEUTICS INC · CUSIP 67080M103 · CIK 1425738

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Log in to see them.
Citable facts

As of Sep 30, 2026, Redmile Group, LLC reported 7.90M NRIX (shares), valued at $187.33M, or 13.71% of its reported non-derivative portfolio. Filed Nov 16, 2026.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
13.71%
Shares
7.90M
7,901,085
Reported value
$187.33M
USD

Shares increased 93.95%; reported value increased 89.55%, and weight changed +7.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q3 202613.71%7,901,085SEC filing ↗Filed Nov 16, 2026
Q2 20266.64%4,073,787SEC filing ↗Filed Aug 14, 2026
Q1 20267.94%7,732,808SEC filing ↗Filed May 15, 2026
Q4 202511.31%8,093,908SEC filing ↗Filed Feb 17, 2026
Q3 20253.31%3,678,394SEC filing ↗Filed Nov 14, 2025
Q2 20254.53%3,732,888SEC filing ↗Filed Aug 14, 2025
Q1 20254.55%4,051,927SEC filing ↗Filed May 15, 2025
Q4 20245.50%4,192,627SEC filing ↗Filed Feb 14, 2025
Q3 20245.67%4,280,981SEC filing ↗Filed Nov 14, 2024
Q2 20245.58%4,423,616SEC filing ↗Filed Aug 14, 2024
Q1 20242.42%4,483,016SEC filing ↗Filed May 15, 2024
Q4 20231.20%3,256,519SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20231.20%3,256,519$33.61MThe prior quarter is outside the free window. Log in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20242.42%4,483,016$65.90MShares increased 37.66%; reported value increased 96.09%, and weight changed +1.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20245.58%4,423,616$92.32MShares decreased 1.33%; reported value increased 40.09%, and weight changed +3.16 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20245.67%4,280,981$96.19MShares decreased 3.22%; reported value increased 4.19%, and weight changed +0.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20245.50%4,192,627$78.99MShares decreased 2.06%; reported value decreased 17.89%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20254.55%4,051,927$48.14MShares decreased 3.36%; reported value decreased 39.06%, and weight changed -0.95 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20254.53%3,732,888$42.52MShares decreased 7.87%; reported value decreased 11.67%, and weight changed -0.02 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20253.31%3,678,394$33.99MShares decreased 1.46%; reported value decreased 20.06%, and weight changed -1.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 202511.31%8,093,908$153.54MShares increased 120.04%; reported value increased 351.75%, and weight changed +8.00 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20267.94%7,732,808$119.86MShares decreased 4.46%; reported value decreased 21.94%, and weight changed -3.37 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20266.64%4,073,787$98.83MShares decreased 47.32%; reported value decreased 17.54%, and weight changed -1.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Q3 202613.71%7,901,085$187.33MShares increased 93.95%; reported value increased 89.55%, and weight changed +7.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 16, 2026
Redmile Group, LLC · NURIX THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_institutional_holdings
{"action":"portfolio","cik":"1425738","quarter":"2026Q3","cusip":"67080M103"}

akkru_institutional_holdings
{"action":"history","cik":"1425738","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP / CLI documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.